LCTX
Price
$0.54
Change
-$0.01 (-1.82%)
Updated
Dec 24, 02:00 PM (EDT)
72 days until earnings call
MGTX
Price
$6.17
Change
+$0.08 (+1.31%)
Updated
Dec 24, 02:00 PM (EDT)
78 days until earnings call
Ad is loading...

LCTX vs MGTX

Header iconLCTX vs MGTX Comparison
Open Charts LCTX vs MGTXBanner chart's image
Lineage Cell Therapeutics
Price$0.54
Change-$0.01 (-1.82%)
VolumeN/A
CapitalizationN/A
MeiraGTx Holdings
Price$6.17
Change+$0.08 (+1.31%)
Volume$9.74K
CapitalizationN/A
LCTX vs MGTX Comparison Chart
Loading...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LCTX vs. MGTX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Hold and MGTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (LCTX: $0.55 vs. MGTX: $6.09)
Brand notoriety: LCTX and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 42% vs. MGTX: 55%
Market capitalization -- LCTX: $120.9M vs. MGTX: $482.21M
LCTX [@Biotechnology] is valued at $120.9M. MGTX’s [@Biotechnology] market capitalization is $482.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than LCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 5 TA indicator(s) are bullish while MGTX’s TA Score has 4 bullish TA indicator(s).

  • LCTX’s TA Score: 5 bullish, 5 bearish.
  • MGTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than MGTX.

Price Growth

LCTX (@Biotechnology) experienced а +9.70% price change this week, while MGTX (@Biotechnology) price change was -3.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.99%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +3.17%.

Reported Earning Dates

LCTX is expected to report earnings on Mar 06, 2025.

MGTX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($482M) has a higher market cap than LCTX($119M). MGTX YTD gains are higher at: -13.248 vs. LCTX (-49.679). LCTX has higher annual earnings (EBITDA): -22.1M vs. MGTX (-61.2M). MGTX has more cash in the bank: 123M vs. LCTX (32.7M). LCTX has less debt than MGTX: LCTX (2.75M) vs MGTX (86.7M). MGTX has higher revenues than LCTX: MGTX (13.9M) vs LCTX (8.72M).
LCTXMGTXLCTX / MGTX
Capitalization119M482M25%
EBITDA-22.1M-61.2M36%
Gain YTD-49.679-13.248375%
P/E RatioN/AN/A-
Revenue8.72M13.9M63%
Total Cash32.7M123M27%
Total Debt2.75M86.7M3%
FUNDAMENTALS RATINGS
LCTX vs MGTX: Fundamental Ratings
LCTX
MGTX
OUTLOOK RATING
1..100
583
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
9039
P/E GROWTH RATING
1..100
67100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (39) in the null industry is in the same range as MGTX (55) in the Biotechnology industry. This means that LCTX’s stock grew similarly to MGTX’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to MGTX’s over the last 12 months.

LCTX's SMR Rating (96) in the null industry is in the same range as MGTX (98) in the Biotechnology industry. This means that LCTX’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's Price Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for LCTX (90) in the null industry. This means that MGTX’s stock grew somewhat faster than LCTX’s over the last 12 months.

LCTX's P/E Growth Rating (67) in the null industry is somewhat better than the same rating for MGTX (100) in the Biotechnology industry. This means that LCTX’s stock grew somewhat faster than MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXMGTX
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 7 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VWSYF13.690.42
+3.14%
Vestas Wind Systems A/S
FFXDF16.070.12
+0.75%
Fairfax India Hldgs Corp
STBFY16.10N/A
+0.01%
Suntory Beverage & Food Ltd
SBGSF247.08-2.02
-0.81%
Schneider Electric SE
ANLDF0.05N/A
-5.84%
Anfield Energy Inc.

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-1.70%
MDGL - LCTX
43%
Loosely correlated
+0.79%
MGTX - LCTX
34%
Loosely correlated
-0.98%
APTO - LCTX
33%
Loosely correlated
-10.82%
AXON - LCTX
33%
Loosely correlated
-1.20%
GBIO - LCTX
33%
Loosely correlated
-7.56%
More